Private Equity 8 Hours

Last updated: June 12, 2026, 5:30 PM ET

Funding Activity & Deal Flow Enterprise‑software specialist Ninja One secured a $400 million round, the largest U.S. financing this week, while blockchain firm Digital Asset attracted a comparable sum, highlighting continued appetite for high‑growth tech despite broader market softness. In Europe, private‑equity sponsor SK Capital saw its portfolio company Spectrum Vascular acquire medical‑device maker Piccolo Medical, expanding the latter’s vascular‑access product line and positioning the combined entity for a potential IPO within three years. Meanwhile, KKR announced a strategic investment in CPA firm Crowe’s advisory business, becoming its first institutional capital partner and signaling a broader push by buyout houses into professional services amid rising demand for compliance expertise.

Fundraising & Capital Allocation* Carlyle disclosed plans to raise roughly $15 billion for its ninth flagship buyout fund, a target that would place the firm among the top global fundraisers despite heightened competition from sovereign wealth funds and the lingering effects of higher interest rates on leveraged‑buyout economics. At the same time, BlackRock imposed a second‑quarter cap on redemptions from its $13 billion private‑credit flagship, reflecting persistent outflows by retail investors seeking liquidity after a year of elevated credit spreads and tightening credit conditions.**

Strategic Acquisitions in Healthcare Healthcare‑focused investment vehicle Healthcare Holding Schweiz, backed by KKA and Winterberg, completed the purchase of Compet Medical, a supplier of harm‑reduction and prevention products to public institutions, expanding its footprint in the European public‑health sector and creating cross‑sell opportunities with existing portfolio assets. In parallel, SK Capital‑backed Apotex pursued a C$1.3 billion IPO, leveraging stable pharmaceutical demand and recent growth in speech‑therapy services, which have attracted interest from General Atlantic and other growth investors targeting niche healthcare subsectors.

Space‑Related Market Catalysts Analysts warned that a potential SpaceX IPO could ignite a $200 billion surge in private‑markets capital as investors chase exposure to the burgeoning commercial‑space economy, a view reinforced by a Bloomberg estimate that the listing could value SpaceX near $1.8 trillion and generate record proceeds for early backers such as Founders Fund, Sequoia and Andreessen Horowitz. The prospect of such a windfall has already prompted several mid‑market private‑equity firms to explore satellite‑technology and space‑logistics targets, anticipating spillover effects across defense and data‑infrastructure portfolios.